The nation of Zimbabwe has rejected a substantial American health deal valued at 367 million US dollars (272 million pounds) over five years due to the United States' demand for confidential data.
The decision came to light following a official document from December was leaked, indicating that President Emmerson Mnangagwa felt the deal was "skewed".
A government spokesperson has since stated that the US was seeking biological samples for scientific study and commercial purposes but was not willing to share the benefits from any future vaccines.
"We are forced to start the difficult and regrettable process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has urged continued dialogue to secure a deal acceptable to all parties so the country's critical HIV treatment initiative can continue.
Wider Implications
This rejection follows a similar situation in neighbouring Kenya, where a high court suspended a related health funding agreement following concerns were raised about the security of citizens' health data.
Since resuming the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had managed assistance for the American government, but Trump argued its spending was "wasteful" and his government was seeking direct bilateral agreements to enhance transparency and accountability.
As per reports, Sixteen nations in Africa have to date signed similar health pacts, constituting over $18.3bn in committed funds.
Specifics of the Rejected Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation would have delivered significant benefits for the people of Zimbabwe, particularly the 1.2 million currently on antiretroviral therapy through American-funded initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".
"Zimbabwe was being asked to provide its genetic material and health information indefinitely, with no equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that shared data," his statement read.
"Effectively, our nation would provide the basic resources for medical research without any certainty that the final treatments would be accessible to our population should a new health crisis arise."
National Interest and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its push of one-on-one health agreements were upending frameworks already established through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing framework designed to manage potential global health emergencies.
"This mechanism is designed to guarantee that when a country contributes its information, the benefits – such as vaccines and treatments – are shared equitably, not monopolised exclusively by those with the funds to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," he added.
"We are open to further discussions with our US partners on how future co-operation could be structured in a way that honours the independence and dignity of each country."
Health Experts Response
A leading public health body expressed it recognised the government's concerns, but urged that talks need to persist since a large portion of the country's HIV programmes depended on external financing.
"In cases where specific concerns arise, such as those relating to information security or implementation frameworks, these can often be resolved via technical clarification and negotiated safeguards," the group added.
The situation emphasises the complex challenges between receiving vital foreign assistance and safeguarding national sovereignty in an increasingly interconnected world.